BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.
about
Beyond disease-progression: Clinical outcomes after EGFR-TKIs in a cohort of EGFR mutated NSCLC patients.ErbB Family Signalling: A Paradigm for Oncogene Addiction and Personalized Oncology.Tissue is the issue and tissue competition. Re-biopsy for mutation T790: where and why?The crucial role of predicting brain metastases development in non-small cell lung cancer patients
P2860
BE-POSITIVE: Beyond progression after tyrosine kinase inhibitor in EGFR- positive non small cell lung cancer patients: Results from a multicenter Italian observational study.
description
2016 nî lūn-bûn
@nan
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
2016年论文
@zh
2016年论文
@zh-cn
name
BE-POSITIVE: Beyond progressio ...... r Italian observational study.
@en
BE-POSITIVE: Beyond progressio ...... r Italian observational study.
@nl
type
label
BE-POSITIVE: Beyond progressio ...... r Italian observational study.
@en
BE-POSITIVE: Beyond progressio ...... r Italian observational study.
@nl
prefLabel
BE-POSITIVE: Beyond progressio ...... r Italian observational study.
@en
BE-POSITIVE: Beyond progressio ...... r Italian observational study.
@nl
P2093
P50
P1433
P1476
BE-POSITIVE: Beyond progressio ...... er Italian observational study
@en
P2093
Alessandro Follador
Antonio Ardizzoia
Claudia Mucciarini
Clelia Casartelli
Elisa Rizzo
Erika Rijavec
Fabiana Cecere
Fausto Barbieri
Gianluca Spitaleri
Giovenzio Genestreti
P356
10.1016/J.LUNGCAN.2016.02.011
P50
P577
2016-02-26T00:00:00Z